http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
『종경록(宗鏡錄)』의 문헌적 성격과 인용된 승조(僧肇)저술의 분석
김주경 ( Kim Ju-gyeong ) 성철사상연구원 2000 백련불교논집 Vol.10 No.-
ZongJingLu, the main subject of this paper, is a large volume of journals by YongMingYanShou(永明延壽904~976) of FaYanZong(法眼宗) in the period of WuDai(五代). ZongJingLu has ever since influenced Buddhism in not only China but also Korea and Japan. It has been frequently referred in journals of many priests and even printed in the second edition of the Tri-pitaka of Korea. However, despite the importance of ZongJingLu as a book of philosophy as well as philology, there has been very few recent research;there is no separate volume on it and it has been only briefly mentioned in literatures on Chinese Buddhism and Zen Buddhism. Even in these research papers, ZongJingLu has been considered as an important literature of Zen Buddhism not that its philosophy has been regarded highly but that it contains a few documents long forgotten or lost. ZongJingLu is a kind of dissertation, not analects. It is not understood well at the moment why a zen priest of his caliber practising the southern Zen Buddhism that puts enormous emphasis on Bu-Li-Wen-Zi (不立文字) and Wu-Nian-Wu-Xiu(無念無修) had ever to write a thesis like ZongJingLu. Therefore, in this paper we firstly will survey the circumstances of the Zen Buddhism in China at the period of YongMingYanShou’s time including the overall situations of Chinese Buddhism, and then discuss the motivation of his writing ZongJingLu. We will also examine the philological aspect of ZongJingLu by analyzing its structure. Finally, we will investigate how its philosophy has been used in journals by following Chinese buddhist, SengZhao(僧肇).
조산 예측을 위한 인슐린 유사 성장인자 결합 단백질-1의 유용성
박옥랑 ( Park Og Lang ),김주경 ( Kim Ju Gyeong ),장보승 ( Chang Bo Seung ),김항진 ( Kim Hang Jin ),김태상 ( Kim Tae Sang ),박일수 ( Park Il Su ) 대한산부인과학회 2003 Obstetrics & Gynecology Science Vol.46 No.7
목적 : 조기 진통의 증상이 있는 산모에서 자궁 경관 분비물내의 인산화 인슐린 유사 성장인자 결합 단백질-1 (phIGFBP-1)의 검출이 조산의 예측에 효과가 있는지 알아보고자 이 연구를 시행하였다. 연구 방법 : 2001년 1월부터 2002년 5월 사이에 조기 진통으로 입원하였던 임산부중 조기 진통의 임박증상이 있으면서 양막 파열이 동반되지 않고 자궁 수축제의 기왕력이 없는 산모를 대상으로 자궁 경관 분비물내의 phIGFBP-1의 정성검사를 시행하여 양성군과 음성군간의 조산에 대한 예측도 및 자궁 수축 억제제와 corticosteroid의 사용 빈도, 분만시 재태 연령 및 신생아 체중 등을 비교 분석하였다. 결과 : phIGFBP-1의 양성군이 음성군에 비하여 37주 이전의 분만 (p<0.001), 34주 이전의 분만 (p=0.008), 입원후 7일 이내의 분만 (p<0.001) 등의 가능성이 더 높았으며 검사의 민감도와 특이도는 각각 77.3%와 85.7%였으며 양성 예측도는 81.0%, 음성 예측도는 82.8%로 태아 파이브로넥틴을 이용한 다른 연구에서의 결과와 비슷하였다. 양성군에서 분만시 재태연령이 더 낮았으며 (p<0.001), 분만시 신생아 체중 역시 더 낮았다 (p<0.001). 결론 : 조기 진통의 임박증상이 있는 환자군에서 phIGFBP-1의 검출은 조기 분만으로서 진행여부를 예측하는데 유용한 검사로 사료된다. Objective : The aim of this study was to evaluate whether the presence of phIGFBP-1 in cervical secretion of patients with symptoms suggestive of preterm labor predicts preterm delivery. Methods : Patients who were examined at the Department of Obstetrics and Gynecology, Daegu Fatima hospital between 24 weeks` and 34 weeks` gestation with intact membrane, no prior tocolysis, symptoms suggestive of preterm labor, and cervical dilatation<3 ㎝ were recruited. Cerviacal swab samples were assayed for the presence of phIGFBP-1 by immunoenzymornetric assay, with a positive result defined as ≥10 ㎍/L, Tocolysis and corticosteroids were used when clinically indicated after specimen collection. Results : phIGFBP-1 was detected in 21 patients among 50 patients analysis. Compared with patients who had negative results, patients who had positive results for phIGFBP-1 were more likely to deliver before 37 weeks (p<0.001), before 34 weeks (p=0.008) and within 7 days (p<0.001). Sensitivity, specificity, positive predictive value and negative predictive value were 77.3%, 85.7%, 81.0%, and 8.28%. Patients with positive results were also treated more with tocolysis and corticosteroids use than patients with negative results. Gestational age at delivery (p<0.001) and birthweight (p<0.001) were lower for patients with positive results. Conclusion : In a population of patients with symptoms, the presence of phIGFBP-1 in cervical secretions defines a subgroup at increased risk for preterm delivery.